Science Explorer Back to mapMap
Discussion
Company · Doylestown · United States

ALS Biopharma (United States)

alsbiopharma.comROR OpenAlex
Research works
26
▲ 91% vs 2018-21
Citations
429
16.5 per fractional work
Top-10% rate
11.4%
all institutions 10.0%
Open access
64%
world 40%
International
30%
world 18%
ALS Biopharma (United States)

Not ranked overall: ALS Biopharma (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ALS Biopharma (United States) work in?

In all years, 37% of research at ALS Biopharma (United States) is in Social Sciences, 31% in Health Sciences. Its largest fields are Medicine (22%), Arts and Humanities (17%), Biochemistry, Genetics and Molecular Biology (11%). It does 1.5× the world's share of Social Sciences.

Social Sciences: 10 fractional works · 37.1% of its workArts and Humanities: 4 fractional works · 16.6% of its workArcheology: 2 fractional works · 8.3% of its workPhilosophy: 1 fractional works · 4.0% of its workLiterature and Literary Theory: 1 fractional works · 3.4% of its workVisual Arts and Performing Arts: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 9.5% of its workSociology and Political Science: 1 fractional works · 3.3% of its workEducation: 1 fractional works · 3.0% of its workLaw: 0 fractional works · 1.3% of its workCultural Studies: 0 fractional works · 1.0% of its workAnthropology: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPsychology: 1 fractional works · 3.8% of its workSocial Psychology: 1 fractional works · 2.6% of its workClinical Psychology: 0 fractional works · 1.3% of its workDecision Sciences: 1 fractional works · 3.3% of its workInformation Systems and Management: 1 fractional works · 2.9% of its workManagement Science and Operations Research: 0 fractional works · 0.4% of its workBusiness, Management and Accounting: 1 fractional works · 2.6% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 2.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.3% of its workEconomics and Econometrics: 0 fractional works · 1.3% of its workHealth Sciences: 8 fractional works · 30.5% of its workMedicine: 6 fractional works · 22.2% of its workNeurology: 1 fractional works · 4.7% of its workPsychiatry and Mental health: 1 fractional works · 3.5% of its workGenetics: 1 fractional works · 2.8% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.6% of its workEpidemiology: 1 fractional works · 2.3% of its workOncology: 0 fractional works · 1.7% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.3% of its workPharmacology: 0 fractional works · 1.3% of its workPhysiology: 0 fractional works · 0.7% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workSurgery: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNursing: 1 fractional works · 4.3% of its workIssues, ethics and legal aspects: 1 fractional works · 3.8% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workHealth Professions: 1 fractional works · 3.4% of its workHealth Information Management: 0 fractional works · 1.5% of its workRadiological and Ultrasound Technology: 0 fractional works · 1.3% of its workPharmacy: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workVeterinary: 0 fractional works · 0.7% of its workSmall Animals: 0 fractional works · 0.7% of its workLife Sciences: 5 fractional works · 18.8% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 11.4% of its workMolecular Biology: 3 fractional works · 11.0% of its workGenetics: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 1 fractional works · 4.5% of its workFood Science: 1 fractional works · 3.8% of its workInsect Science: 0 fractional works · 0.7% of its workNeuroscience: 1 fractional works · 2.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.7% of its workSensory Systems: 0 fractional works · 0.4% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workImmunology and Microbiology: 0 fractional works · 0.4% of its workImmunology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 4 fractional works · 13.6% of its workComputer Science: 2 fractional works · 5.9% of its workComputational Theory and Mathematics: 1 fractional works · 3.8% of its workInformation Systems: 0 fractional works · 1.5% of its workArtificial Intelligence: 0 fractional works · 0.3% of its workComputer Science Applications: 0 fractional works · 0.3% of its workChemistry: 1 fractional works · 3.8% of its workOrganic Chemistry: 1 fractional works · 2.4% of its workPhysical and Theoretical Chemistry: 0 fractional works · 1.0% of its workSpectroscopy: 0 fractional works · 0.4% of its workEnvironmental Science: 1 fractional works · 3.4% of its workEcology: 0 fractional works · 1.3% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.8% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.7% of its workEnvironmental Chemistry: 0 fractional works · 0.7% of its workEngineering: 0 fractional works · 0.5% of its workBuilding and Construction: 0 fractional works · 0.5% of its workMaterials Science: 0 fractional works · 0.0% of its workALL ITS WORKALS Biopharma(United States)26fractional works, all years
Life Sciences19%Physical Sciences14%Health Sciences31%Social Sciences37%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Arts and Humanities416.6%
    2. Social Sciences29.5%
    3. Psychology13.8%
    4. Decision Sciences13.3%
    5. Business, Management and Accounting12.6%
    6. Economics, Econometrics and Finance01.3%
    1. Medicine622.2%
    2. Nursing14.3%
    3. Health Professions13.4%
    4. Veterinary00.7%
    1. Biochemistry, Genetics and Molecular Biology311.4%
    2. Agricultural and Biological Sciences14.5%
    3. Neuroscience12.5%
    4. Immunology and Microbiology00.4%
    1. Computer Science25.9%
    2. Chemistry13.8%
    3. Environmental Science13.4%
    4. Engineering00.5%
    5. Materials Science00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.26× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 1.22× its world share, 0 worksImmunology and Micro…Computer Science: 0.63× its world share, 0 worksComputer ScienceEngineering: 0.12× its world share, 0 worksEngineeringEnvironmental Science: 2.13× its world share, 1 worksEnvironmental ScienceHealth Professions: 4.07× its world share, 1 worksHealth ProfessionsMedicine: 0.43× its world share, 1 worksMedicineVeterinary: 15.01× its world share, 0 worksVeterinaryArts and Humanities: 3.53× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 2.53× its world share, 1 worksBusiness, Management…Decision Sciences: 8.44× its world share, 1 worksDecision SciencesPsychology: 4.02× its world share, 1 worksPsychologySocial Sciences: 1.61× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 15.0×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Veterinary15.01×0 works
  2. Decision Sciences8.44×1 works
  3. Health Professions4.07×1 works
  4. Psychology4.02×1 works
  5. Arts and Humanities3.53×1 works
  6. Business, Management and Accounting2.53×1 works
  7. Environmental Science2.13×1 works
  8. Social Sciences1.61×2 works
  9. Immunology and Microbiology1.22×0 works
  10. Computer Science0.63×0 works
  11. Medicine0.43×1 works
  12. Biochemistry, Genetics and Molecular Biology0.26×0 works
  13. Engineering0.12×0 works

What are the most cited papers from ALS Biopharma (United States)?

The most cited paper from ALS Biopharma (United States) is "Considerations of Environmentally Relevant Test Conditions for Improved Evaluation of Ecological Hazards of Engineered Nanomaterials" (Patricia Ann Holden et al., 2016), with 235 citations. Next come "Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation" (97) and "The role of sulfamide derivatives in medicinal chemistry: a patent review (2006 – 2008)" (87).

Most cited papers
#PaperReleasedCitations
1 Considerations of Environmentally Relevant Test Conditions for Improved Evaluation of Ecological Hazards of Engineered Nanomaterials Patricia Ann Holden et al. · Environmental Science & Technology Open access 13 May 2016 235
2 Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation Alyssa N. Coyne, Shizuka B. Yamada, Bhavani Bagevalu Siddegowda et al. · Human Molecular Genetics Open access 18 Sep 2015 97
3 The role of sulfamide derivatives in medicinal chemistry: a patent review (2006 – 2008) Allen B. Reitz, Garry R. Smith, Michael H. Parker · Expert Opinion on Therapeutic Patents 4 Aug 2009 87
4 Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: Characterization of inhibition by nucleic acids and 4-aminoquinolines Joel A. Cassel, Allen B. Reitz · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics Open access 27 Mar 2013 65
5 Novel inhibitors of heat shock protein Hsp70-mediated luciferase refolding that bind to DnaJ Joel A. Cassel, Sergey Olegovich Ilyin, Mark E. McDonnell et al. · Bioorganic & Medicinal Chemistry 12 Apr 2012 33
All 23 most cited papers, with filters and sorting

Which keywords describe research at ALS Biopharma (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Iberian Peninsula, Archaeology, Neurodegeneration, Settlement Patterns, Health Policy, Medicinal Chemistry, FUS/TLS and Molecular Docking.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Iberian Peninsula2▲ 218×3 topics
  2. Public Health1▲ 3.9×3 topics
  3. Archaeology1▲ 34×2 topics
  4. Health Policy1▲ 33×2 topics
  5. Medicinal Chemistry1▲ 13×4 topics
  6. Neurodegeneration1▲ 16×3 topics
  7. Settlement Patterns1▲ 212×2 topics
  8. Sustainability1▲ 2.6×3 topics
  9. FUS/TLS1▲ 220×1 topic
  10. Genetics1▲ 5.7×2 topics
  11. Molecular Docking1▲ 29×2 topics
  12. Nanoparticles1▲ 3.2×4 topics
  13. Nursing Education1▲ 35×2 topics
  14. TDP-431▲ 220×1 topic
  15. Climate Change1▲ 1.44×2 topics
  16. Drug Target Identification1▲ 55×1 topic
  17. Nursing Advocacy1▲ 210×1 topic
  18. Occultism1▲ 261×1 topic
  19. Political Participation1▲ 47×1 topic
  20. Protein Aggregation1▲ 48×2 topics
  21. Spiritualism1▲ 261×1 topic
  22. Team Science1▲ 224×2 topics
  23. Virtual Screening1▲ 55×1 topic

Which research topics does ALS Biopharma (United States) publish most on?

By volume in 2022-now: Technostress in Professional Settings, Organizational Learning and Leadership, Innovation, Sustainability, Human-Machine Systems and Intensive Care Unit Cognitive Disorders.

Technostress in Professional Settings: 1 fractional worksOrganizational Learning and Leadership: 1 fractional worksInnovation, Sustainabili…1Innovation, Sustainability, Human-Machine Systems: 1 fractional worksIntensive Care Unit Cogn…0Intensive Care Unit Cognitive Disorders: 0 fractional worksFamily and Patient Care in Intensive Care Units: 0 fractional worksInterdisciplinary Research and Collaboration: 0 fractional worksCOVID-19 and Mental Health0COVID-19 and Mental Health: 0 fractional worksResearch Data Management Practices: 0 fractional worksHealthcare Regulation: 0 fractional worksScientific Computing and…0Scientific Computing and Data Management: 0 fractional works
Social PsychologyOrganizational Behavior and Human Resource ManagementSociology and Political ScienceCritical Care and Intensive Care Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Technostress in Professional Settings Social Psychology 1 works
  2. 2 Organizational Learning and Leadership Organizational Behavior and Human Resource Management 1 works
  3. 3 Innovation, Sustainability, Human-Machine Systems Sociology and Political Science 1 works
  4. 4 Intensive Care Unit Cognitive Disorders Critical Care and Intensive Care Medicine 0 works
  5. 5 Family and Patient Care in Intensive Care Units Radiological and Ultrasound Technology 0 works
  6. 6 Interdisciplinary Research and Collaboration Information Systems and Management 0 works
  7. 7 COVID-19 and Mental Health Clinical Psychology 0 works
  8. 8 Research Data Management Practices Information Systems 0 works
  9. 9 Healthcare Regulation Health Information Management 0 works
  10. 10 Scientific Computing and Data Management Information Systems and Management 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available63.9%not open36.1%

World: 40% of research is openly available.

with international co-authors29.8%domestic only70.2%

World: 18% is written across borders.

How has ALS Biopharma (United States)'s research output changed?

Output in 2022-2025 was 91% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ALS Biopharma (United States) as a percentage of every work published that year, 0.000012% in 2024.

still counting0.00010%0.00020%0.00030%ALS Biopharma (United States)0.000044% in 20251990200020102020

Fractional works of ALS Biopharma (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Doylestown

All research institutions in Doylestown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ALS Biopharma (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.